The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The comparative effectiveness of glasdegib in combination with low-dose cytarabine versus azacitidine by bone marrow blasts counts among patients with newly-diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy.
 
Sophie van Beekhuizen
Employment - Ingress Health
Consulting or Advisory Role - Ingress Health
Research Funding - Ingress Health
Travel, Accommodations, Expenses - Ingress Health
 
Yannan Hu
Employment - Ingress Health
Consulting or Advisory Role - Ingress Health
Research Funding - Ingress Health
Travel, Accommodations, Expenses - Ingress Health
 
Ana Gezin
Employment - Ingress Health
Consulting or Advisory Role - Ingress Health
Research Funding - Ingress Health (Inst)
Travel, Accommodations, Expenses - Ingress Health
 
Bart Heeg
Employment - Ingress Health
Consulting or Advisory Role - Ingress Health
Research Funding - Ingress Health
Travel, Accommodations, Expenses - Ingress Health
 
Timothy Bell
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Majed Charaan
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Andrew Brown
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Geoffrey Chan
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Joseph C Cappelleri
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer